Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Reexamination Certificate
2005-09-06
2005-09-06
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
C514S415000, C514S460000
Reexamination Certificate
active
06939897
ABSTRACT:
The present invention has for its object to provide a method and a composition for achieving a more efficient recovery of the antioxidant activity of plasma LDL, or even augmentation thereof, which has been depressed by the use of an antihyperlipidemic or cholesterol-lowering drug to thereby insure a potentiated antiarteriosclerotic efficacy. A method for inhibiting arteriosclerosis, which comprises using a combination of a cholesterol-lowering agent and a reduced coenzyme Q10represented by the following formula (1), and a composition for inhibiting arteriosclerosis containing both a cholesterol-lowering agent and said reduced coenzyme Q10.
REFERENCES:
patent: 4929437 (1990-05-01), Tobert
patent: 5082650 (1992-01-01), Folkers et al.
patent: 5316765 (1994-05-01), Folkers et al.
patent: 0 383 432 (1990-08-01), None
patent: 0 882 450 (1998-12-01), None
Fujii Kenji
Hidaka Takayoshi
Hosoe Kazunori
Kawabe Taizo
Henley III Raymond J.
Kaneka Corporation
Sughrue & Mion, PLLC
LandOfFree
Method and composition for inhibiting arteriosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for inhibiting arteriosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for inhibiting arteriosclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3436312